Civica Partners With Phlow To Build $125m Injectables Facility In US

Operations Expected To Begin Within Three Years

 
• By Dean Rudge

Lauding a “dream come true,” Civica has announced plans to build its own injectables manufacturing facility via a strategic partnership with fellow public health firm Phlow Corporation.

Strategy
Building US manufacturing space has been a part of Civica’s supply strategy since it was founded in 2018 • Source: Shutterstock

More from Manufacturing

More from Business